Solvay Raises Offer for Biotech Firm

Solvay says it has increased its offer to acquire biotechnological firm Innogenetics (Gent, Belgium) from €5.75/share in cash, to €6.50/share in cash. The higher offer values the deal at €200.7 million for all of the outstanding shares, Solvay says. This is a 74% premium to the closing price of April 24, 2008, the day before Solvay’s initial offer. Solvay says it raised its offer price following a €215-million bid for Innogenetics from Gen-Probe (San Diego) in June. The deal between Solvay and Inogenetics is expected to close during...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers